FORTUNATO, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 1.861
AS - Asia 1.321
EU - Europa 861
SA - Sud America 344
Continente sconosciuto - Info sul continente non disponibili 133
AF - Africa 44
OC - Oceania 2
Totale 4.566
Nazione #
US - Stati Uniti d'America 1.780
SG - Singapore 591
IT - Italia 443
BR - Brasile 255
CN - Cina 236
VN - Vietnam 169
IN - India 107
DE - Germania 88
HK - Hong Kong 87
EE - Estonia 85
FI - Finlandia 48
AR - Argentina 47
CA - Canada 43
BD - Bangladesh 40
GB - Regno Unito 38
NL - Olanda 28
MX - Messico 20
RU - Federazione Russa 20
ID - Indonesia 19
FR - Francia 18
SE - Svezia 18
IQ - Iraq 15
ZA - Sudafrica 15
CO - Colombia 12
JP - Giappone 12
EC - Ecuador 11
ES - Italia 11
PK - Pakistan 11
AT - Austria 10
PL - Polonia 9
CZ - Repubblica Ceca 8
SC - Seychelles 6
UA - Ucraina 6
PE - Perù 5
TN - Tunisia 5
VE - Venezuela 5
CH - Svizzera 4
CL - Cile 4
GR - Grecia 4
MA - Marocco 4
NI - Nicaragua 4
PT - Portogallo 4
SA - Arabia Saudita 4
TR - Turchia 4
DO - Repubblica Dominicana 3
DZ - Algeria 3
EG - Egitto 3
JM - Giamaica 3
JO - Giordania 3
KE - Kenya 3
TT - Trinidad e Tobago 3
UZ - Uzbekistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
AO - Angola 2
AZ - Azerbaigian 2
BE - Belgio 2
BG - Bulgaria 2
CR - Costa Rica 2
LT - Lituania 2
LV - Lettonia 2
MT - Malta 2
PS - Palestinian Territory 2
PY - Paraguay 2
RS - Serbia 2
TW - Taiwan 2
UY - Uruguay 2
AL - Albania 1
AU - Australia 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
CI - Costa d'Avorio 1
DK - Danimarca 1
ET - Etiopia 1
GE - Georgia 1
HR - Croazia 1
HU - Ungheria 1
IE - Irlanda 1
IL - Israele 1
IR - Iran 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MD - Moldavia 1
NP - Nepal 1
PA - Panama 1
PH - Filippine 1
QA - Qatar 1
RO - Romania 1
RW - Ruanda 1
SV - El Salvador 1
TH - Thailandia 1
TV - Tuvalu 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.436
Città #
Dallas 411
San Jose 314
Singapore 274
Ashburn 169
Santa Clara 117
Hong Kong 84
Bengaluru 79
Council Bluffs 72
Chandler 66
Hefei 64
Beijing 62
Munich 59
Ho Chi Minh City 58
Hanoi 44
Milan 44
Rome 39
Turku 30
Chicago 29
Los Angeles 26
Boardman 23
London 23
São Paulo 22
New York 20
Lawrence 19
Princeton 19
Helsinki 18
Orem 16
Buffalo 14
Catanzaro 13
Wilmington 13
Naples 12
San Francisco 11
Brooklyn 10
Da Nang 10
Genoa 10
Secaucus 10
Mexico City 9
Reggio Calabria 9
Warsaw 9
Amsterdam 8
Bari 8
Boston 8
Chennai 8
Johannesburg 8
Montreal 8
Palermo 8
Pasadena 8
Mingora 7
Piacenza 7
Rio de Janeiro 7
San Nicola Manfredi 7
Toronto 7
Dhaka 6
Piscataway 6
Rimini 6
Seattle 6
Settingiano 6
Stockholm 6
Tokyo 6
Atlanta 5
Brasília 5
Guayaquil 5
Haiphong 5
Lamezia Terme 5
Olomouc 5
Paris 5
Valmadrera 5
Assago 4
Aversa 4
Belo Horizonte 4
Biên Hòa 4
Bogotá 4
Buenos Aires 4
Cabo Frio 4
Can Tho 4
Carrara 4
Curitiba 4
Falerna 4
Frankfurt am Main 4
Huế 4
Lima 4
Managua 4
Porto Alegre 4
Pune 4
Taranto 4
Verona 4
Alessandria 3
Baghdad 3
Carney 3
Castrolibero 3
Caxias do Sul 3
Charlotte 3
Como 3
Crotone 3
Denver 3
Elk Grove Village 3
Florianópolis 3
Giugliano in Campania 3
Guangzhou 3
Hanover 3
Totale 2.630
Nome #
Predictive factors of Status Epilepticus and its recurrence in patients with adult–onset seizures: A multicenter, long follow–up cohort study 149
Levetiracetam vs Lamotrigine as First-Line Antiseizure Medication in Female Patients With Idiopathic Generalized Epilepsy 145
Comparative Effectiveness of Brivaracetam, Cenobamate, Lacosamide, and Perampanel in Focal Epilepsy 113
Efficacy of rehabilitative techniques in reducing hemiplegic shoulder pain in stroke: systematic review and meta-analysis 104
Effectiveness of perampanel as only concomitant antiseizure medication for highly active epilepsy: insight from a real-world, multicenter retrospective study 100
Adjunctive Brivaracetam in Focal Epilepsy: Real-World Evidence from the BRIVAracetam add-on First Italian netwoRk STudy (BRIVAFIRST) 97
Glucose transporter-1 deficiency syndrome with extreme phenotypic variability in a five-generation family carrying a novel SLC2A1 variant 95
Adjunctive cenobamate in people with focal onset seizures: Insights from the Italian Expanded Access Program 81
Varicella zoster immunity loss in multiple sclerosis patient treated with ocrelizumab 81
Effectiveness and Safety of Adjunctive Cenobamate in People with Focal-Onset Epilepsy: Evidence from the First Interim Analysis of the BLESS Study 80
A real-world comparison among third-generation antiseizure medications: Results from the COMPARE study 78
Efficacy of Virtual Reality and Exergaming in Improving Balance in Patients With Multiple Sclerosis: A Systematic Review and Meta-Analysis 74
Phenotypic Variability in Novel Doublecortin Gene Variants Associated with Subcortical Band Heterotopia 71
Adjunctive Brivaracetam in People with Epilepsy and Intellectual Disability: Evidence from the BRIVAracetam Add-On First Italian netwoRk Study 71
Facemask headache: a new nosographic entity among healthcare providers in COVID-19 era 70
Perampanel as first add-on choice on the treatment of mesial temporal lobe epilepsy: an observational real-life study 69
Distinguishing seizures in autoimmune limbic encephalitis from mesial temporal lobe epilepsy with hippocampal sclerosis: Clues of a temporal plus network 68
Idiopathic generalized epilepsy in a family with SCN4A-related myotonia 68
Effectiveness of perampanel as the only add‐on: Retrospective, multicenter, observational real‐life study on epilepsy patients 67
Circulating microrna: The potential novel diagnostic biomarkers to predict drug resistance in temporal lobe epilepsy, a pilot study 67
Pain Management and Rehabilitation for Central Sensitization in Temporomandibular Disorders: A Comprehensive Review 66
Exome sequencing of 20,979 individuals with epilepsy reveals shared and distinct ultra-rare genetic risk across disorder subtypes 65
Climate change and hyponatremia-related hospital admissions in people with focal epilepsy exposed to carbamazepine or its derivatives 64
Perampanel in post-stroke epilepsy: Clinical practice data from the PERampanel as Only Concomitant antiseizure medication (PEROC) study 63
National survey on the prevalence of single-gene aetiologies for genetic developmental and epileptic encephalopathies in Italy 62
Adjunctive brivaracetam and sustained seizure frequency reduction in very active focal epilepsy 62
A familial t(4;8) translocation segregates with epilepsy and migraine with aura 61
Exploring the Effectiveness of Adjunctive Cenobamate in Focal Epilepsy: A Time-Based Analysis 59
Novel KCNQ2 Variants Related to a Variable Phenotypic Spectrum Ranging from Epilepsy with Auditory Features to Severe Developmental and Epileptic Encephalopathies 58
Predictors of Seizure Recurrence in Women With Idiopathic Generalized Epilepsy Who Switch From Valproate to Another Medication 58
Brand-to-Generic Levetiracetam Switching: a four-years prospective observational real-life study 57
The impact of one-year COVID-19 containment measures in patients with mesial temporal lobe epilepsy: A longitudinal survey-based study 57
Serum MicroRNAs as Predictors of Diagnosis and Drug-resistance in Temporal Lobe Epilepsy: A Preliminary Study 56
Genome-wide association meta-analyses of drug-resistant epilepsy 55
Orbito-frontal thinning together with a somatoform dissociation might be the fingerprint of PNES 55
Neuromuscular Impairment of Knee Stabilizer Muscles in a COVID-19 Cluster of Female Volleyball Players: Which Role for Rehabilitation in the Post-COVID-19 Return-to-Play? 54
Personality disorders in individuals with functional seizures: a systematic review 53
May anti‐seizure medications alter brain structure in temporal lobe epilepsy? A prospective study 53
Topiramate ban in women of childbearing potential with idiopathic generalized epilepsy: Does effectiveness offset the teratogenic risks? 53
Brivaracetam as add-on treatment in patients with post-stroke epilepsy: real-world data from the BRIVAracetam add-on First Italian netwoRk Study (BRIVAFIRST) 53
Second-Line Medications for Women Aged 10 to 50 Years with Idiopathic Generalized Epilepsy 51
Electroclinical Features and Long-term Seizure Outcome in Patients With Eyelid Myoclonia With Absences 51
Hereditary Spastic Paraplegia Associated with Ultra-Rare Variant Enrichment Encompassing the SYNE1, CAPN1 and PGAP1 Genes 51
Ultrasound-Guided Injections and Proprioceptive Neuromuscular Facilitation as Shoulder Rehabilitation for Multiple Sclerosis and Neuropathic Pain 50
Epilepsy, Immunity and Neuropsychiatric Disorders 50
Brivaracetam as Early Add-On Treatment in Patients with Focal Seizures: A Retrospective, Multicenter, Real-World Study 49
Sustained seizure freedom with adjunctive brivaracetam in patients with focal onset seizures 49
Italian report on RARE epilepsies (i-RARE): A consensus on multidisciplinarity 49
Focal epilepsy with sensory seizures associated with arginine:glycine amidinotransferase deficiency: A clinical and advanced magnetic resonance imaging study 48
Lamotrigine vs levetiracetam in female patients of childbearing age with juvenile absence epilepsy: A Bayesian reanalysis 48
Two Novel Variants in the CHRNA2 and SCN2A Genes in Italian Patients with Febrile Seizures 48
Functional activity changes in memory and emotional systems of healthy subjects with déjà vu. 47
Patterns of subregional cerebellar atrophy across epilepsy syndromes: An ENIGMA‐Epilepsy study 46
Temporomandibular disorders and neck pain in primary headache patients: a retrospective machine learning study 46
Correction to: Adjunctive Brivaracetam in Focal Epilepsy: Real‑World Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST) (CNS Drugs, (2021), 35, 12, (1289-1301), 10.1007/s40263-021-00856-3) 46
Epileptic belly dancing: a video-polygraphic recording 46
The spectrum of epilepsy with eyelid myoclonia: delineation of disease subtypes from a large multicenter study 44
Neuroma of the Inferior Alveolar Nerve: A Treatable Mimic of Refractory Trigeminal Neuralgia 44
Neuropsychiatric profile in average intelligent individuals with coexisting epilepsy and psychogenic non-epileptic seizures 43
Non-Coding RNAs: New Biomarkers and Therapeutic Targets for Temporal Lobe Epilepsy 42
Focal neuromyotonia associated with a C9ORF72 expansion mutation 42
Late drug-resistance in mild MTLE: Can it be influenced by preexisting white matter alterations? 41
Tremor as an intrinsic feature of juvenile myoclonic epilepsy 39
Effects of intensive rehabilitation on functioning in patients with mild and moderate Charcot–Marie-Tooth disease: a real-practice retrospective study 39
Epilepsy with generalized tonic–clonic seizures alone: Electroclinical features and prognostic patterns 39
Climate change and disorders of the nervous system 38
PAK3 pathogenic variant associated with sleep-related hypermotor epilepsy in a family with parental mosaicism 38
Babylonian knowledge about temporal lobe epilepsy: distinguishing mesial from lateral forms 36
Exosomes from Human Periapical Cyst-MSCs: Theranostic Application in Parkinson's Disease 35
Lacosamide is Associated with a Higher Treatment Persistence at 12 Months than Brivaracetam and Perampanel Despite Similar Efficacy 35
Late-Onset Ictal Asystole and Falls Related to Severe Coronary Artery Stenosis: A Case Report 34
null 33
Brand-to-generic levetiracetam switching: a 4-year prospective observational real-life study 33
GWAS meta-analysis of over 29,000 people with epilepsy identifies 26 risk loci and subtype-specific genetic architecture 30
Event-based modeling in temporal lobe epilepsy demonstrates progressive atrophy from cross-sectional data 26
Sex-based electroclinical differences and prognostic factors in epilepsy with eyelid myoclonia 25
National survey on the prevalence of single-gene aetiologies for genetic developmental and epileptic encephalopathies in Italy 24
Effect of patient-related factors on brivaracetam efficacy and tolerability: results from a multicentric, retrospective study 23
Adjunctive Brivaracetam in Older Patients with Focal Seizures: Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST) 22
Epilepsy beyond seizures: embracing a holistic perspective. Proceedings of the 2nd meeting (Episicily) of the epilepsy study group of the Italian Society of neurology 22
The bidirectional association of epilepsy with Alzheimer's disease and other neurodegenerative dementias: A longitudinal observational study on the UK Biobank 14
Response: Letter to the Editor – Climate, hyponatremia, and epilepsy: A critical signal demanding broader scrutiny 10
Phenotypic traits and family history in patients with 22q11.2 deletion syndrome and generalized epilepsy: A multicenter case–control study 9
Nabiximols improves sleep architecture in multiple sclerosis: A prospective polysomnographic study 7
Impact of Age on the Diagnostic Yield of Routine EEG in People With Childhood or Juvenile Absence Epilepsy: A Cross‐Sectional Study 5
Generation of hiPSCs lines from PRICKLE2-mutant individuals with epilepsy 4
Characterization of Sleep in Alternating Hemiplegia of Childhood: An International Survey 3
Totale 4.566
Categoria #
all - tutte 27.335
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.335


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202288 0 0 0 10 7 14 5 15 16 8 11 2
2022/2023241 44 24 20 40 18 20 2 14 22 7 19 11
2023/2024190 27 30 13 14 19 22 17 14 6 4 6 18
2024/2025989 53 21 23 78 88 123 72 43 77 103 103 205
2025/20262.814 139 209 511 482 253 113 254 130 323 222 134 44
2026/2027207 65 142 0 0 0 0 0 0 0 0 0 0
Totale 4.566